Excepting a higher frequency of CD4+IFN+ T cells in unstimulated samples in myeloma patients, there were no other differences regarding unstimulated and CEF-Peptides- stimulated samples in the two patient groups (Figure S3B). This evidence concerns the gene IFNA1 and plasma cell myeloma.